Analystreport

BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report